Search results
FDA to review RI biotech firm's cell therapy for eye disease - Providence Business First
The Business Journals· 3 days agoA Rhode Island biotech that's developing new treatments for diseases of the eye said its application has been accepted for review by the FDA. Neurotech Pharmaceuticals Inc ...
Roche, local startup Ascidian sign $1.8B deal for neurological medicines - Boston Business Journal
The Business Journals· 6 days agoAscidian Therapeutics has signed a deal with Roche in the Boston startup’s first-ever partnership....
Cantor Fitzgerald Reaffirms Overweight Rating for Skye Bioscience (NASDAQ:SKYE)
ETF DAILY NEWS· 6 days agoCantor Fitzgerald restated their overweight rating on shares of Skye Bioscience (NASDAQ:SKYE – Free...
Akari Therapeutics (NASDAQ:AKTX) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 5 days agoStockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report released on Wednesday morning. The firm issued a sell rating on the biopharmaceutical ...
Skye Bioscience (NASDAQ:SKYE) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 6 days agoSkye Bioscience (NASDAQ:SKYE – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Cantor Fitzgerald in a research report issued on Monday, Benzinga reports ...
REGENXBIO Inc. (NASDAQ:RGNX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 5 days agoShares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the stock, Marketbeat.com reports ...
Lawmaker warns of legislative action over UI animal research concerns
The Gazette· 3 days agoResponding to demands from a state lawmaker and Iowa’s Human Society director — made last week after...
Effect of manual OCTA segmentation correction to improve image quality and visibility of choroidal...
Nature· 7 days agoIn this retrospective case series on neovascular age-related macular degeneration (nAMD), we aimed to improve Choroidal Neovascularization (CNV) visualization ...